35% response rate in the ADP-A2M4CD8 monotherapy cohort with ~5 months median duration of response in heavily pre-treated patients across a broad range of solid tumors 50% response rate in 26 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback